Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

GT Biopharma (GTBP) Assets Average (2016 - 2021)

GT Biopharma (GTBP) has disclosed Assets Average for 10 consecutive years, with $37.7 million as the latest value for Q3 2021.

  • On a quarterly basis, Assets Average rose 3706.31% to $37.7 million in Q3 2021 year-over-year; TTM through Sep 2021 was $37.7 million, a 3706.31% increase, with the full-year FY2020 number at $3.0 million, changed N/A from a year prior.
  • Assets Average was $37.7 million for Q3 2021 at GT Biopharma, up from $33.6 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $256.2 million in Q2 2018 to a low of $131500.0 in Q1 2017.
  • A 5-year average of $66.4 million and a median of $21.1 million in 2019 define the central range for Assets Average.
  • Peak YoY movement for Assets Average: surged 276055.68% in 2017, then tumbled 98.67% in 2020.
  • GT Biopharma's Assets Average stood at $255.4 million in 2017, then tumbled by 44.89% to $140.8 million in 2018, then crashed by 99.69% to $439000.0 in 2019, then soared by 649.2% to $3.3 million in 2020, then soared by 1045.71% to $37.7 million in 2021.
  • Per Business Quant, the three most recent readings for GTBP's Assets Average are $37.7 million (Q3 2021), $33.6 million (Q2 2021), and $16.7 million (Q1 2021).